A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza

Clinical trial NCT03394209 · COMPLETED

Trial details

NCT number: NCT03394209
Sponsor: Capital Medical University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza, Human Critical Illness Influenza

Start date: 2018-02-06
Primary completion: 2019-02-20
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.